Incidence of thrombophilia in patients with Gaucher disease

American Journal of Medical Genetics

Volumn 95, Issue 5, 2000, Pages 429-431

  Elstein, D ^a   Renbaum, P ^a   Levy Lahad, E ^a   Zimran, A ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Anticardiolipin; Avascular necrosis; Factor V; Hypercoagulability; MTHFR; Prothrombin

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; PROTHROMBIN;

ARTICLE; AVASCULAR NECROSIS; DISEASE PREDISPOSITION; GAUCHER DISEASE; GENE FREQUENCY; GENE MUTATION; HETEROZYGOSITY; HUMAN; HYPERCOAGULABILITY; INCIDENCE; PERTHES DISEASE; PRIORITY JOURNAL; RISK FACTOR; THROMBOPHILIA;

ANTIBODIES, ANTICARDIOLIPIN; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; FACTOR V; FEMALE; GAUCHER DISEASE; HETEROZYGOTE; HUMANS; HYPERTENSION, PULMONARY; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NECROSIS; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PROTHROMBIN; RISK FACTORS; THROMBOPHILIA;

EID: 0034684728     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-8628(20001218)95:5<429::AID-AJMG4>3.0.CO;2-6     Document Type: Article

References (23)

1. Prothrombin mutant, factor V Leiden, and thermolabile variant of methylenetetrahydrofolate reductase among patients with sickle cell disease in Brazil
2. Inherited risk factors for thrombophilia among children with Legg-Calve-Perthes disease
3. Effect of splenectomy on destructive bone changes in children with chronic (Type I) Gaucher disease
4. Replacement therapy for inherited enzyme deficiency: Macrophage-targeted glucocerebrosidase for Gaucher disease
5. Mutation in blood coagulation factor V associated with resistance to activated protein C
6. The clinical course of treated and untreated Gaucher disease. A study of 45 patients
7. Glucosylceramide lipidoses
8. Coagulation abnormalities in patients with Gaucher disease: Effect of therapy
9. The role of neurogenetics in Gaucher disease
10. Clinicopathologic correlations of the phospholipid syndrome
11. Skeletal involvement in Gaucher disease
12. Echocardiographic assessment of pulmonary hypertension in Gaucher disease
13. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
14. Coagulation abnormalities in type 1 Gaucher disease are due to low-grade activation and can be partly restored by enzyme supplementation therapy
15. Increased blood viscosity in patients with Legg-Perthes disease: A preliminary report
16. MTHFR (5,10-methylenetetrahydrofolate reductase) 677C→T mutation as a candidate risk factor for avascular necrosis (AVN) in patients with sickle cell disease
17. A common genetic variation in the 3-prime-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
18. High frequency of factor V Leiden in a population of Israeli Arabs
19. Enzyme replacement therapy for Gaucher disease: Skeletal responses to macrophage-targeted glucocerebrosidase
20. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity
21. Inherited DNA mutations contributing to thrombotic complications in patients with sickle cell disease
22. Outcome of partial splenectomy in type I Gaucher disease
23. Gaucher disease: Clinical, laboratory, radiologic, and genetic features of 53 patients